SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
AmerisourceBergen Corporation (ABC) trades at a trailing P/E of 22.6. Trailing earnings yield is 4.42%. PEG 3.97.
Criteria proven by this page:
- VALUE (53/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- PEG Ratio 3.97 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 4.42% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
- Analyst consensus target $171.00 (-5% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 51/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
53/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ABC
Valuation Multiples
P/E (TTM)22.6
Forward P/EN/A
PEG Ratio3.97
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.11
EV/EBITDA0.0
Per Share Data
EPS (TTM)$7.96
Book Value / Share$0.00
Revenue / Share$1,646.05
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.42%
Dividend Yield0.00%
Analyst Target$171.00 (-5%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$6.32 |
$146.85B |
$1.43B |
1% |
| 2017 |
$1.87 |
$153.14B |
$414.48M |
0.3% |
| 2018 |
$7.53 |
$167.94B |
$1.66B |
1% |
| 2019 |
$4.04 |
$179.59B |
$855.37M |
0.5% |
| 2020 |
$-16.60 |
$189.89B |
$-3.4B |
-1.8% |
| 2021 |
$7.39 |
$213.99B |
$1.54B |
0.7% |
| 2022 |
$8.04 |
$238.59B |
$1.7B |
0.7% |
| 2023 |
$8.53 |
$262.17B |
$1.75B |
0.7% |
| 2024 |
$7.53 |
$293.96B |
$1.51B |
0.5% |
| 2025 |
$7.96 |
$321.33B |
$1.55B |
0.5% |
